secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dogwood Therapeutics, Inc. (DWTX)
CIK:        0001818844
Form:       8-K
Filed at:   2024-06-20T23:59:59+00:00
Accession:  0001558370-24-009327
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Virios Therapeutics annual meeting elects all six director nominees, ratifies FORVIS as auditor
--------------------------------------------------------------------------------

- Quorum of 8,699,494 shares (45.17% of voting power) present at June 18, 2024 meeting.
- All six director nominees elected: Burch (3,201,273 for), De La Rosa (2,440,247), Duncan (3,183,237), Keefer (3,198,840), Thomas (3,201,528), Whitley (1,964,627).
- Highest withheld votes were for Dr. Whitley with 1,442,138 withheld.
- Ratification of FORVIS LLP as auditor for FY2024 approved with 8,347,686 for, 241,056 against, 110,752 abstain.
- No broker non-votes on auditor ratification; broker non-votes of 5,292,729 on director elections.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818844/000155837024009327/0001558370-24-009327-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818844/000155837024009327/viri-20240618x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-009327

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer